ArticleJournal for immunotherapy of cancer2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study.
Karlijn de Joode et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.